Febuxostat: a new drug for an old disease. Do we really need it?

BACKGROUND Febuxostat is a non-purine selective inhibitor of xanthine oxidase whose therapeutic effect is decreasing the serum uric acid concentration. Febuxostat has a marketing authorisation for the treatment of chronic hyperuricaemia in conditions where urate/uric acid deposition has already occu...

Full description

Bibliographic Details
Main Authors: Giovanni Gulli, Luigi de Filippis
Format: Article
Language:English
Published: PAGEPress Publications 2013-04-01
Series:Italian Journal of Medicine
Subjects:
Online Access:http://www.italjmed.org/index.php/ijm/article/view/261